Cancer Pathology Data Sharing
2.0.0 - STU 2 United States of America flag

Cancer Pathology Data Sharing, published by HL7 International / Orders and Observations. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cancer-reporting/ and changes regularly. See the Directory of published versions

Table of Contents

Page standards status: Informative
.. 0 Table of Contents
... 1 Home
... 2 Background
... 3 Cancer Pathology Observation Example
... 4 Change Notes
... 5 Downloads
... 6 Specification
... 7 Artifacts Summary
.... 7.1 Central Cancer Registry Reporting Pathology EHR Capability Statement
.... 7.2 Pathology Laboratory Information System
.... 7.3 US Pathology Bundle
.... 7.4 US Pathology Composition Laboratory Report
.... 7.5 US Pathology Diagnostic Report
.... 7.6 US Pathology Observation
.... 7.7 US Pathology Related Practitioner Role
.... 7.8 US Pathology Service Request
.... 7.9 US Pathology Specimen
.... 7.10 Document DiagnosticReport Reference
.... 7.11 CAP eCP Answer Codes
.... 7.12 CAP eCP Form Codes
.... 7.13 CAP eCP Question Codes
.... 7.14 CAP eCP Section Codes
.... 7.15 US Pathology Form Category Codes
.... 7.16 US Pathology Provider Types
.... 7.17 US Pathology Code System
.... 7.18 Additional Dimension Observation
.... 7.19 Additional Findings Observation example
.... 7.20 Additional Findings Section
.... 7.21 Breast Biomarker Testing Performed on Previous Biopsy
.... 7.22 Breast Specimen Example
.... 7.23 Breast Tissue Excision Observation Example
.... 7.24 Closest Margin(s) to Invasive Carcinoma example
.... 7.25 Comments Section
.... 7.26 Composition - Examination of Resection Specimens from Patients with Invasive Carcinoma of the Breast
.... 7.27 Distant Metastasis Distant Site(s) Involved Observation example
.... 7.28 Distant Metastasis Observation example
.... 7.29 Distant Metastasis Section
.... 7.30 Ductal Carcinoma In Situ Observation Example
.... 7.31 Estrogen Receptor (ER) Status
.... 7.32 General Tumor Site Observation
.... 7.33 Glandular/Tubular Differentiation Observation Example
.... 7.34 HER2 (by immunohistochemistry)
.... 7.35 HER2 Observation Example
.... 7.36 Histologic Grade Observation Example
.... 7.37 Histologic Type Observation example
.... 7.38 Lymph Nodes Section
.... 7.39 Margin Distance from Invasive Carcinoma to Closest Margin example
.... 7.40 Margin Status for Invasive Carcinoma Observation example
.... 7.41 Margins Section
.... 7.42 Mitotic Rate Observation Example
.... 7.43 Next-of-Kin RelatedPerson example
.... 7.44 Nuclear Pleomorphism Observation Example
.... 7.45 Number of Sentinel Nodes Examined
.... 7.46 Observation for Clock Position General
.... 7.47 Oncologist Practitioner example
.... 7.48 Oncologist PractitionerRole example
.... 7.49 Overall Grade Observation Example
.... 7.50 Pathologist Practitioner example
.... 7.51 Pathology specimen collection procedure example
.... 7.52 Patient example
.... 7.53 Principal Pathology Lab example
.... 7.54 PTNM Classification Observation example
.... 7.55 pTNM Classification Section
.... 7.56 Redwood Women's Center, P.C. example
.... 7.57 Regional Lymph Nodes PT Category Observation example
.... 7.58 Regional Lymph Nodes Section
.... 7.59 Regional Lymph Nodes Status Observation example
.... 7.60 Service Request - Cancer Pathology example
.... 7.61 Special Studies Estrogen Receptor
.... 7.62 Special Studies Section
.... 7.63 Specific Clock Position Observation (8 o'clock)
.... 7.64 Specimen Laterality Observation Example
.... 7.65 Specimen Section
.... 7.66 Surgeon Practitioner example
.... 7.67 Surgeon PractitionerRole example
.... 7.68 Total Number of Lymph Nodes Examined (sentinel and non-sentinel) example
.... 7.69 Tumor Extent Observation Example
.... 7.70 Tumor Focality Observation Example
.... 7.71 Tumor Section
.... 7.72 Tumor Size Observation
.... 7.73 US Pathologist PractitionerRole example
.... 7.74 US Pathology Breast Invasive Carcinoma DiagnosticReport example
.... 7.75 US Pathology Encounter Specimen Collection example
.... 7.76 US Pathology Exchange bundle example